| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8212204 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 29 Pages |
Abstract
PCE was common after RT for NSCLC, occurring in nearly half of patients even after moderate radiation doses to the heart. Adjuvant chemotherapy may increase the risk of PCE, and HV35Â >10% may identify patients at risk of development of this cardiac toxicity.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Matthew S. MD, Linglong MD, Daniel R. MD, Ting PhD, Yangkun MD, Jinhai MD, PhD, Elie MD, Zhongxing MD,